ADAP
Adaptimmune Therapeutics
ADAP
ADAP
92 hedge funds and large institutions have $577M invested in Adaptimmune Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 7 closing their positions.
Holders
92
Holders Change
+10
Holders Change %
+12.2%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
30
Reduced
23
Closed
7
Calls
$2.49M
Puts
$1.96M
Net Calls
+$531K
Net Calls Change
+$530K